Senyurek Sukran, Aygun Murat Serhat, Kilic Durankus Nulifer, Akdemir Eyub Yasar, Sezen Duygu, Topkan Erkan, Bolukbasi Yasemin, Selek Ugur
Department of Radiation Oncology, School of Medicine, Koc University, 03457 Istanbul, Turkey.
Department of Radiology, Altunizade Acibadem Hospital, 03457 Istanbul, Turkey.
Brain Sci. 2024 Sep 15;14(9):922. doi: 10.3390/brainsci14090922.
BACKGROUND/OBJECTIVES: The objective of this study was to assess the connection between the systemic inflammation response index (SIRI) values and failure patterns of patients with IDH wild-type glioblastoma (GB) who underwent radiotherapy (RT) with FLAIR-based gross tumor volume (GTV) delineation.
Seventy-one patients who received RT at a dose of 60 Gy to the GTV and 50 Gy to the clinical target volume (CTV) and had documented recurrence were retrospectively analyzed. Each patient's maximum distance of recurrence (MDR) from the GTV was documented in whichever plane it extended the farthest. The failure patterns were described as intra-GTV, in-CTV/out-GTV, distant, and intra-GTV and distant. For analytical purposes, the failure pattern was categorized into two groups, namely Group 1, intra-GTV or in-CTV/out-GTV, and Group 2, distant or intra-GTV and distant. The SIRI was calculated before surgery and corticosteroid administration. A receiver operating characteristic (ROC) curve analysis was used to determine the optimal SIRI cut-off that distinguishes between the different failure patterns.
Failure occurred as follows: intra-GTV in 40 (56.3%), in-CTV/out-GTV in 4 (5.6%), distant in 18 (25.4%), and intra-GTV + distant in 9 (12.7%) patients. The mean MDR was 13.5 mm, and recurrent lesions extended beyond 15 mm in only seven patients. Patients with an SIRI score ≥ 3 demonstrated a significantly higher incidence of Group 1 failure patterns than their counterparts with an SIRI score < 3 (74.3% vs. 50.0%; = 0.035).
The present results show that using the SIRI with a cut-off value of ≥3 significantly predicts failure patterns. Additionally, the margin for the GTV can be safely reduced to 15 mm when using FLAIR-based target delineation in patients with GB.
背景/目的:本研究的目的是评估全身炎症反应指数(SIRI)值与异柠檬酸脱氢酶(IDH)野生型胶质母细胞瘤(GB)患者接受基于液体衰减反转恢复序列(FLAIR)的大体肿瘤体积(GTV)勾画的放射治疗(RT)后的失败模式之间的关联。
回顾性分析71例接受60 Gy剂量的GTV和50 Gy剂量的临床靶体积(CTV)放疗且有复发记录的患者。记录每位患者从GTV的最大复发距离(MDR),以其延伸最远的平面为准。失败模式分为GTV内、CTV内/ GTV外、远处转移以及GTV内和远处转移。为便于分析,将失败模式分为两组,即第1组,GTV内或CTV内/ GTV外;第2组,远处转移或GTV内和远处转移。在手术和使用皮质类固醇之前计算SIRI。采用受试者工作特征(ROC)曲线分析来确定区分不同失败模式的最佳SIRI临界值。
失败情况如下:40例(56.3%)为GTV内复发,4例(5.6%)为CTV内/ GTV外复发,18例(25.4%)为远处转移,9例(12.7%)为GTV内 + 远处转移。平均MDR为13.5 mm,仅7例患者的复发灶延伸超过15 mm。SIRI评分≥3的患者第1组失败模式的发生率显著高于SIRI评分<3的患者(74.3%对50.0%;P = 0.035)。
目前的结果表明,使用临界值≥3的SIRI可显著预测失败模式。此外,在GB患者中使用基于FLAIR的靶区勾画时,GTV的边界可安全地缩小至15 mm。